ClinicalTrials.gov
ClinicalTrials.gov Menu

PMS of Trazenta on the Long-term Use as Add-on Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01904383
Recruitment Status : Active, not recruiting
First Posted : July 22, 2013
Last Update Posted : April 13, 2018
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : September 30, 2018
  Estimated Study Completion Date : September 30, 2018